
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-09 | Column Group IV GP, LP | 10% Owner | Purchase | 2.12M | $18.00 | $38.12M | 4.31M | View ↗ | |
| 2026-02-04 | 2026-02-06 | Foresite Capital Management IV, LLC | 10% Owner | Purchase | 55.6K | $18.00 | $1000K | 1.32M | View ↗ | |
| 2026-02-04 | 2026-02-06 | FRAZIER KENNETH C | Director | Purchase | 111.1K | $18.00 | $2.00M | 111.1K | View ↗ | |
| 2026-02-04 | 2026-02-06 | Wolfe Josh | Director | Purchase | 138.9K | $18.00 | $2.50M | 138.9K | View ↗ |
No financial data available for EIKN.
Company may not file with SEC or CIK is unresolved.
Largest IPOs of the last 90 days register mixed debut
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Alibaba Set To Report Earnings While Investors Watch Out For Jobs Data
Catalyst Watch: Jobs report, new Apple products, and a spotlight on software